Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kura Oncology (NQ: KURA ) 20.54 +0.36 (+1.78%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Kura Oncology < Previous 1 2 3 4 Next > KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024 August 08, 2024 KURA stock results show that Kura Oncology beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace 7 ‘Death Cross’ Stocks That Could Be Contrarian Buys July 17, 2024 Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. Via InvestorPlace Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END Via FinancialNewsMedia 2 Incredible Growth Stocks to Buy Hand Over Fist May 08, 2024 These two healthcare growth stocks could have a lot more room to run. Via The Motley Fool Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6 March 06, 2024 Via Investor Brand Network Kura Oncology: Q4 Earnings Insights February 27, 2024 Via Benzinga Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 From FN Media Group LLC Via GlobeNewswire KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024 May 02, 2024 KURA stock results show that Kura Oncology missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga Earnings Outlook For Kura Oncology February 26, 2024 Via Benzinga Kura Oncology Inc. (NASDAQ: KURA) Near the Top of Equities by Percentage Gain on 1/24 January 24, 2024 Via Investor Brand Network A Preview Of Kura Oncology's Earnings November 01, 2023 Via Benzinga Analyst Expectations for Kura Oncology's Future September 07, 2023 Via Benzinga MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential February 22, 2024 MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. Via Talk Markets Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15% January 30, 2024 The company just released promising results for its acute myeloid leukemia treatment. Via Investor's Business Daily Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 30, 2024 Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales Via Benzinga Why Cancer-Drug Developer Kura Oncology Stock Is Up January 30, 2024 Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all... Via Benzinga General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday January 30, 2024 U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Dow Edges Lower; US Composite PMI Rises In January January 24, 2024 U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 24, 2024 Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 24, 2024 Via Benzinga Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today? January 24, 2024 Latest surge in Kura Oncology shares with a $150 million private placement announcement. Cash runway extended into 2027. Via Benzinga Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday January 24, 2024 U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Wednesday. Shares of Textron Inc. (NYSE: TXT) rose during Wednesday’s session following upbeat quarterly earnings. Via Benzinga Topics Stocks Exposures US Equities Kura Oncology Rockets 39% Before Unveiling Cancer Drug Test Results — Here's Why January 24, 2024 Kura Oncology is still a week out from unveiling the results for an AML drug. But shares soared Wednesday. Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 24, 2024 Via Benzinga Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst December 22, 2023 Mizuho initiated coverage on Kura Oncology Inc (NASDAQ: KURA), spotlighting the potential of ziftomenib as a first-in-class treatment for relapsed/refractory (r/r) NPM1-m acute myeloid leukemia... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 27, 2023 Via Benzinga Kura Oncology's Head & Neck Cancer Candidate Shows Meaningful Antitumor Activity In Pretreated Patients October 18, 2023 Kura Oncology Inc (NASDAQ: KURA) announced results from its registration-directed AIM-HN study of tipifarnib in patients with HRAS mutant head and neck squamous cell carcinoma (HNSCC) whose disease is... Via Benzinga Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP® Technology September 13, 2023 Allarity Therapeutics (NASDAQ: ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. Via Benzinga Sushi, Bans, And Business: Japan's Radioactive Water Release Sparks Concerns For US Seafood Traders August 25, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.